281 related articles for article (PubMed ID: 20945454)
1. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?
Cavalieri EL; Rogan EG
IUBMB Life; 2010 Oct; 62(10):746-51. PubMed ID: 20945454
[TBL] [Abstract][Full Text] [Related]
2. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
Cavalieri E; Rogan E
Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
[TBL] [Abstract][Full Text] [Related]
3. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones.
Cavalieri EL; Rogan EG
Ann N Y Acad Sci; 2004 Dec; 1028():247-57. PubMed ID: 15650250
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
[TBL] [Abstract][Full Text] [Related]
5. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
Cavalieri E; Rogan E
Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
[TBL] [Abstract][Full Text] [Related]
6. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3',4'-quinone or enzyme-activated 3'-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens.
Saeed M; Gunselman SJ; Higginbotham S; Rogan E; Cavalieri E
Steroids; 2005 Jan; 70(1):37-45. PubMed ID: 15610895
[TBL] [Abstract][Full Text] [Related]
7. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of depurinating estrogen-DNA adduct formation by natural compounds.
Zahid M; Gaikwad NW; Rogan EG; Cavalieri EL
Chem Res Toxicol; 2007 Dec; 20(12):1947-53. PubMed ID: 18039013
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens.
Saeed M; Rogan E; Cavalieri E
Int J Cancer; 2009 Mar; 124(6):1276-84. PubMed ID: 19089919
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic insights into the Michael addition of deoxyguanosine to catechol estrogen-3,4-quinones.
Stack DE; Li G; Hill A; Hoffman N
Chem Res Toxicol; 2008 Jul; 21(7):1415-25. PubMed ID: 18547067
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation and formation of DNA adducts of hexestrol, a synthetic nonsteroidal carcinogenic estrogen.
Jan ST; Devanesan PD; Stack DE; Ramanathan R; Byun J; Gross ML; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1998 May; 11(5):412-9. PubMed ID: 9585471
[TBL] [Abstract][Full Text] [Related]
13. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.
Lu F; Zahid M; Saeed M; Cavalieri EL; Rogan EG
J Steroid Biochem Mol Biol; 2007; 105(1-5):150-8. PubMed ID: 17582757
[TBL] [Abstract][Full Text] [Related]
14. Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3',4'-quinone. Implications for mutagenic activity.
Saeed M; Zahid M; Gunselman SJ; Rogan E; Cavalieri E
Steroids; 2005 Jan; 70(1):29-35. PubMed ID: 15610894
[TBL] [Abstract][Full Text] [Related]
15. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
[TBL] [Abstract][Full Text] [Related]
16. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
17. A unified mechanism in the initiation of cancer.
Cavalieri EL; Rogan EG
Ann N Y Acad Sci; 2002 Apr; 959():341-54. PubMed ID: 11976208
[TBL] [Abstract][Full Text] [Related]
18. Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.
Cavalieri EL; Rogan EG
J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):169-80. PubMed ID: 21397019
[TBL] [Abstract][Full Text] [Related]
19. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract.
Markushin Y; Zhong W; Cavalieri EL; Rogan EG; Small GJ; Yeung ES; Jankowiak R
Chem Res Toxicol; 2003 Sep; 16(9):1107-17. PubMed ID: 12971798
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation.
Zahid M; Saeed M; Lu F; Gaikwad N; Rogan E; Cavalieri E
Free Radic Biol Med; 2007 Dec; 43(11):1534-40. PubMed ID: 17964424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
